Clinical Trial Update: A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating an activated-dendritic cell–based Hepatitis B vaccine in combination with anti-HBV drugs for chronic hepatitis B; the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Activated-dendritic cell-based Hepatitis B vaccine
• HBV antiviral drugs

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: UNKNOWN